NCT07214051Completed
PR-CEAL: Community Outreach Engagement Group
Source: ClinicalTrials.gov · Last updated 9 Oct 2025
Brief summary (registry, in English)
The United States Preventive Services Task Force (USPSTF) recommends regular screenings for breast, cervical, and colorectal cancer. The COVID-19 pandemic has disrupted health screening practices, leading to a decrease in cancer screenings among the United States including Puerto Rico. This has been attributed to unwillingness, distrust, and insecurity related to accessing healthcare services. To overcome these challenges, a collaboration between PR-CEAL's Community Outreach Engagement Group (COEG), academic researchers, healthcare institutions, and community-based organizations proposed to engage in different community activities throughout the island. In these events, investigators conducted a single blinded community-based Randomized Clinical Trial (RCT) regarding cancer screening practices in women 21 through 75 years. The community-based RCT employed a mixed-method design to gain insights into the perception of health and cancer screening status of participants regarding breast, uterine (cervical), and colorectal cancer. Data was collected through in person interviews and two follow up phone calls, enabling the researchers to obtain valuable sociodemographic information, assessing cancer screening history, and identifying existing barriers. The hypothesis of this study is that implementing evidence-based intervention at community settings across Puerto Rico will have a significant positive effect on cancer screening rates among non-adherent patients. By identifying and adapting the Prevention Care Management for Cancer Screening intervention and leveraging the expertise of the National Cancer Institute, the study aimed to improve screening rates, address barriers that hinder or delay screenings, and raise awareness about the importance of early detection.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 500 (actual)
- First submitted
- 19 Sept 2025
- Start date
- 13 Dec 2023
- Primary completion date
- 12 Jul 2024
- Lead sponsor
- University of Puerto Rico Comprehensive Cancer Center
- Diseases
- Cervical cancer, Colorectal cancer
- NCT number
- NCT07214051
What you commit to
- Study type: Interventional
- Participants enrolled: 500
- From 13 Dec 2023 to the primary completion date, 12 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants that are not overdue in any cancer screening (breast, cervical or colorectal), according to the USPTF guidelines.
- Participants that are in active cancer treatment.
Age
- Women younger than 21 years or older than 75 years.
Other
- Male
- Participants that are cognitive, mental or physically limited.
- Participants who are not able to read.
- Participants who don't have access to a telephone.
Who the study is looking for
- Women
- Between 21 and 75 years old
- Participant is overdue in at least one cancer screening (breast, cervical or colorectal), according to the USPTF guidelines.
- Participants that have not reported any cognitive, mental or physical limitation.
- Ability to read.
- Access to a telephone.
- Participants that are not in active cancer treatment.
Age in the registry: 21 years to 75 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Puerto Rico, Comprehensive Cancer Center Coordinator of this site? Confirm its status | San Juan | Puerto Rico | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.